An intermediate-conductance Ca2+-activated K+ channel mediates B lymphoma cell cycle progression induced by serum

Pflugers Archiv European Journal of Physiology

Volumn 454, Issue 6, 2007, Pages 945-956

  Wang, Jing ^a   Xu, Yu Qing ^b   Liang, You You ^a   Gongora, Rafael ^c   Warnock, David G ^a   Ma, He Ping ^a  

^a University of Alabama at Birmingham   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c The University of Alabama at Birmingham   (United States)

Author keywords

Calcium activated potassium channel; Cell cycle; Confocal microscopy; Insulin like growth factor; Intracellular calcium; Lymphocyte; Patch clamp

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CD20 ANTIBODY; MARGATOXIN; MONOCLONAL ANTIBODY; TETRYLAMMONIUM;

ARTICLE; CALCIUM CONDUCTANCE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DAUDI CELL; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD20; CALCIUM; CELL CYCLE; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MORPHOLINES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAZOLES; SERUM; TETRAETHYLAMMONIUM; UP-REGULATION;

EID: 34548315744     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0258-7     Document Type: Article

References (41)

1. Avivi I, Robinson S, Goldstone A (2003) Clinical use of rituximab in haematological malignancies. Br J Cancer 89:1389-1394
2. Beck TW, Magnuson NS, Rapp UR (1995) Growth factor regulation of cell cycle progression and cell fate determination. Curr Top Microbiol Immunol 194:291-303
3. Berridge MJ (1995) Calcium signalling and cell proliferation. BioEssays 17:491-500
4. Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ, Kunzelmann K, Bubendorf L (2006) KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene DOI 10.1038/sj.onc.1210036 (in press)
5. + conductance found constitutively in B lymphocytes. J Cell Biol 121:1121-1132
6. Chang KL, Kamel OW, Arber DA, Horyd ID, Weiss LM (1995) Pathologic features of nodular lymphocyte predominance Hodgkin's disease in extranodal sites. Am J Surg Pathol 19:1313-1324
7. Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, Matifat F (2006) The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol 71:843-851
8. Conforti L, Petrovic M, Mohammad D, Lee S, Ma Q, Barone S, Filipovich AH (2003) Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J Immunol 170:695-702
9. + channels in human T lymphocytes: a role in mitogenesis?. Nature 307:465-468
10. Fanger CM, Rauer H, Neben AL, Miller MJ, Rauer H, Wulff H, Rosa JC, Ganellin CR, Chandy KG, Cahalan MD (2001) Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 276:12249-12256
11. Gallagher JD, Noelle RJ, McCann FV (1995) Mercury suppression of a potassium current in human B lymphocytes. Cell Signal 7:31-38
12. + channels via PI3-kinase, PDK1 and SGK1. Pflugers Arch 443:625-634
13. Gongora R, Stephan RP, Zhang Z, Cooper MD (2001) An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. Immunity 14:727-737
14. + channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25:704-709
15. Grimberg A (2003) Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2:630-635
16. Helms MN, Liu L, Liang YY, Al-Khalili O, Vandewalle A, Saxena S, Eaton DC, Ma HP (2005) Phosphatidylinositol 3,4,5-trisphosphate mediates aldosterone stimulation of epithelial sodium channel (ENaC) and interacts with γ-ENaC. J Biol Chem 280:40885-40891
17. + channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol 65:630-638
18. + channels. Proc Natl Acad Sci USA 96:10917-10921
19. 2+ channel in skeletal muscle myoblasts: involvement of a CD20-like protein. J Cell Physiol 197:53-60
20. Kanzaki M, Nie L, Shibata H, Kojima I (1997) Activation of a calcium-permeable cation channel CD20 expressed in Balb/c 3T3 cells by insulin-like growth factor-I. J Biol Chem 272:4964-4969
21. Kanzaki M, Shibata H, Mogami H, Kojima I (1995) Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells. J Biol Chem 270:13099-13104
22. Kojima I, Matsunaga H, Kurokawa K, Ogata E, Nishimoto I (1988) Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factor-I. J Biol Chem 263:16561-16567
23. ATP channels: effects on cell cycle progression in rodent islets. J Biol Chem 281:3261-3267
24. Liebau S, Propper C, Bockers T, Lehmann-Horn F, Storch A, Grissmer S, Wittekindt OH (2006) Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation. J Neurochem 99:426-437
25. Ca channels that hyperpolarize the membrane and enhance calcium influx. J Gen Physiol 113:81-96
26. Ma H, Ling BN (1996) Luminal adenosine receptors regulate amiloride-sensitive Na channels in A6 distal nephron cells. Am J Physiol 270:F798-F805
27. ATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting. J Biol Chem 275:26050-26057
28. McCann FV, McCarthy DC, Noelle RJ (1990) Patch-clamp profile of ion channels in resting murine B lymphocytes. J Membr Biol 114:175-188
29. Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA, Surmacz E (1997) Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int J Cancer 72:828-834
30. + channels in breast cancer cells: association with cell cycle progression. Am J Physiol 287:C125-C134
31. Pardo LA (2004) Voltage-gated potassium channels in cell proliferation. Physiology 19:285-292
32. Partiseti M, Choquet D, Diu A, Korn H (1992) Differential regulation of voltage- and calcium-activated potassium channels in human B lymphocytes. J Immunol 148:3361-3368
33. Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ (1989) Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 49:4906-4912
34. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ (1979) Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279-1283
35. Sutro JB, Vayuvegula BS, Gupta S, Cahalan MD (1989) Voltage-sensitive ion channels in human B lymphocytes. Adv Exp Med Biol 254:113-122
36. Tedder TF, Engel P (1994) CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol Today 15:450-454
37. Wilker E, Lu J, Rho O, Carbajal S, Beltran L, DiGiovanni J (2005) Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog 44:137-145
38. Wonderlin WF, Strobl JS (1996) Potassium channels, proliferation and G1 progression. J Membr Biol 154:91-107
39. Wonderlin WF, Woodfork KA, Strobl JS (1995) Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165:177-185
40. + channel in enhanced cell proliferation by ATP in brain endothelial cells. J Biol Chem 281:38430-38439
41. Zhou ZH, Unlap MT, Li L, Ma H (2002) Incomplete inactivation of voltage-dependent potassium channels in human B lymphoma cells. J Membr Biol 188:97-105